Traynor Capital Management’s Inspire Medical Systems INSP Stock Holding History

Traynor Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,250	Closed	-$232K	–	284
2024 Q4	$232K	Hold	1,250	–	–	0.02%	221
2024 Q3	$264K	Buy	+1,250	New	+$217K	0.02%	196
2024 Q2	–	Sell	-1,100	Closed	-$236K	–	299
2024 Q1	$236K	Hold	1,100	–	–	0.02%	208
2023 Q4	$224K	Hold	1,100	–	–	0.02%	187
2023 Q3	$218K	Hold	1,100	–	–	0.03%	175
2023 Q2	$357K	Hold	1,100	–	–	0.04%	141
2023 Q1	$257K	Hold	1,100	–	–	0.04%	158
2022 Q4	$277K	Buy	+1,100	New	+$235K	0.04%	150
2022 Q3	–	Sell	-1,100	Closed	-$200K	–	189
2022 Q2	$200K	Sell	1,100 -10	-0.9%	-$1.99K	0.03%	150
2022 Q1	$284K	Hold	1,110	–	–	0.04%	141
2021 Q4	$255K	Hold	1,110	–	–	0.03%	160
2021 Q3	$258K	Hold	1,110	–	–	0.04%	158
2021 Q2	$224K	Hold	1,110	–	–	0.03%	161
2021 Q1	$229K	Hold	1,110	–	–	0.04%	147
2020 Q4	$208K	Buy	+1,110	New	+$181K	0.04%	140

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Traynor Capital Management's INSP Position: Q1 2025 in Review

Traynor Capital Management sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 1,250 shares — an estimated $232K sold.

Traynor Capital Management first reported a position in INSP in Q4 2020 and held it in 15 quarters. The position peaked at $357K in Q2 2023. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

Traynor Capital Management reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
Traynor Capital Management sold 1,250 Inspire Medical Systems shares in Q1 2025, an estimated $232K.
Traynor Capital Management first reported a position in Inspire Medical Systems in Q4 2020 and held it in 15 quarters.
Traynor Capital Management's Inspire Medical Systems position peaked at $357K in Q2 2023.
363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Traynor Capital Management's 13F filing for Q1 2025, filed 12 May 2025.